Qing Wen Huang
Keine laufenden Positionen mehr
Vermögen: 4 Mio $ am 30.04.2024
Profil
Qing Wen Huang worked as a Director at Guangdong Eashu Pharmaceutical Co., Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.12.2023 | 5 519 480 ( 2,52% ) | 4 Mio $ | 30.04.2024 |
Ehemalige bekannte Positionen von Qing Wen Huang
| Unternehmen | Position | Ende |
|---|---|---|
Guangdong Eashu Pharmaceutical Co., Ltd.
 Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Guangdong Eashu Pharmaceutical Co., Ltd.
Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Health Technology |
